Cargando…

Reply: CPET for Long COVID-19

Detalles Bibliográficos
Autores principales:	Mancini, Donna M., Natelson, Benjamin H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier on behalf of the American College of Cardiology Foundation 2022
Materias:	Letter To the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884261/ https://www.ncbi.nlm.nih.gov/pubmed/35241251 http://dx.doi.org/10.1016/j.jchf.2022.01.009

Ejemplares similares

CPET for Long COVID-19
por: Naeije, Robert, et al.
Publicado: (2022)

Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors
por: Crisafulli, Ernesto, et al.
Publicado: (2021)

Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2022)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Reply to “Digging deeper on the neurophysiological assessment in COVID-19 patients” and “Myopathy in acute and long-term COVID-19”
por: Hameed, Sajid, et al.
Publicado: (2022)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Dyspnea and Exercise Limitation in Mild COPD: The Value of CPET
por: James, Matthew D., et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?
por: Lala, Anuradha, et al.
Publicado: (2020)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Reply to: Cadaverless anatomy: Darkness in the times of pandemic Covid-19
por: Murlimanju, B.V., et al.
Publicado: (2020)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

Reply to “Impact of COVID-19 on the mental health of radiologists”
por: Demirjian, Natalie L., et al.
Publicado: (2021)

Reply to professionally responsible COVID-19 vaccination counseling
por: Chervenak, Frank A., et al.
Publicado: (2021)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Evaluation of Dynamic Respiratory Mechanical Abnormalities During Conventional CPET
por: Milne, Kathryn M., et al.
Publicado: (2020)

Reply to “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care”
por: Ather, Amber, et al.
Publicado: (2020)

Author’s Reply—COVID-19 vaccination and torsades de pointes
por: Abrich, Victor, et al.
Publicado: (2022)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Liu, Bin, et al.
Publicado: (2020)

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

In Reply — COVID-19, the Female Immune Advantage, and Cardiovascular Impact
por: Ritter, Oliver, et al.
Publicado: (2021)

Reply to the Letter to the Editor “Pathogenesis of pneumoperitoneum in COVID-19 patients”()
por: Gemio del Rey, Ignacio Antonio, et al.
Publicado: (2021)

Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
por: Pillarsetty, Nagavarakishore, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8too9kvkb6kki0u9u82l8cf6ju